Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$42.57 USD

42.57
739,250

-0.06 (-0.14%)

Updated Sep 27, 2024 04:00 PM ET

After-Market: $42.57 0.00 (0.00%) 7:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (164 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Bruker (BRKR) International Growth Strong Amid Competition

Bruker (BRKR) Nano Group's microelectronics and semiconductor metrology tools continue to perform well with ongoing strength in bookings and backlog.

Here's Why Investors Should Retain Charles River (CRL) Now

Investors are optimistic about Charles River's (CRL) strong segmental growth and notable collaborations.

3 Reasons to Add QuidelOrtho (QDEL) Stock to Your Portfolio Now

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

Here's Why You Should Buy ShockWave Medical (SWAV) Stock

ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment to clinical studies.

LabCorp (LH) to Strengthen Laboratory Footprint in Japan

LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.

3 Reasons to Retain Veeva Systems (VEEV) Stock in Your Portfolio

Veeva Systems' (VEEV) slew of strategic deals raises optimism about the stock.

NuVasive (NUVA) to Expand in APAC With New Experience Center

NuVasive's (NUVA) Singapore Experience Center will complement the flagship Experience Centers in San Diego and the New York metropolitan area.

Reasons to Add Patterson Companies (PDCO) to Your Portfolio

Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS (STE) owing to its robust segmental results and the ongoing Cantel Medical integration.

Cigna (CI) Divests Units to Chubb for Net $5.1 Billion

Cigna (CI) closes the deal to divest its life, accident and supplemental benefits businesses to Chubb. CI primarily intends to pursue share repurchases with proceeds received from the transaction.

Quest Diagnostics' (DGX) Base Business Grows Despite Margin Woes

Quest Diagnostics (DGX) continues to make inroads with its health plans, gaining share and increasing revenues faster than the market.

BD's (BDX) New Combination Test to Boost Patient Outcome

BD's (BDX) latest combination test is expected to speed up the detection of the infection-causing viruses, thereby accelerating the implementation of the appropriate treatment plan.

Intuitive (ISRG) New Lung Biopsy Imaging Technology Gets FDA Nod

The FDA clears the integration of mobile cone-beam CT imaging technology with Intuitive's (ISRG) Ion Endoluminal System, enhancing a physician's ability to provide minimally invasive lung biopsy.

Catalent (CTLT) Expands Packaging Capabilities at Japan Facility

Catalent's (CTLT) latest capability expansion is expected to boost its business in this key hub in its Asia-Pacific Clinical Supply Services network.

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

Integer Holdings (ITGR) continues to gain momentum from improving non-medical sales and a solid foothold in the broader MedTech space. However, intense competition persists.

Exact Sciences (EXAS) Cologuard Growth Robust Amid Margin Woes

Exact Sciences' (EXAS) legacy Screening business is growing on impressive Cologuard volume growth and revenue contributions from the PreventionGenetics acquisition.

Cardinal Health (CAH) Ties Up to Deliver Products Via Drones

Cardinal Health's (CAH) latest collaboration is expected to significantly boost its distribution strategy and improve patient service.

3 Reasons to Retain Catalent (CTLT) Stock in Your Portfolio

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.

Omnicell (OMCL) Up 10% Since Q1 Earnings: What's Driving It?

Investors are optimistic about Omnicell's (OMCL) strategic partnerships and continued innovations for the Autonomous Pharmacy.

Illumina's (ILMN) GRAIL to Offer Galleri Test in Indianapolis

Illumina's (ILMN) division GRAIL will offer the Galleri MCED blood test to eligible patients across the Community Health Network's care sites.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Patterson Companies (PDCO) Q4 Earnings Beat, Revenues Up Y/Y

Patterson Companies' (PDCO) fiscal fourth-quarter 2022 results benefit from strength in the Dental and Animal Health segments.

Align (ALGN) Gains From Increased Case Shipment Amid FX Woes

Align Technology's (ALGN) focus on expanding its global operations, both in existing and emerging international markets, raises optimism.

AMN Healthcare Services (AMN) Stock Moves -0.92%: What You Should Know

AMN Healthcare Services (AMN) closed the most recent trading day at $111.41, moving -0.92% from the previous trading session.